To the Editor: We read with interest the review by Lancini and colleagues on cytomegalovirus (CMV) in immunocompetent patients.1 This topic and its associations with ocular disease has garnered increased recognition in the eye care community.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.